These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1435974)

  • 1. Clinical parallels of chronic drug self-administration models for treatment evaluation.
    Mendelson JH; Mello NK
    NIDA Res Monogr; 1992; 119():170-4. PubMed ID: 1435974
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine effects on human heroin self-administration: an operant analysis.
    Mello NK; Mendelson JH; Kuehnle JC
    J Pharmacol Exp Ther; 1982 Oct; 223(1):30-9. PubMed ID: 7120124
    [No Abstract]   [Full Text] [Related]  

  • 3. Operant analysis of human heroin self-administration and the effects of naltrexone.
    Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
    J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin self-administration: an operant analysis.
    Mendelson JH; Mello NK
    NIDA Res Monogr; 1978 Jul; (20):128-48. PubMed ID: 101850
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
    Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
    Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral pharmacology of buprenorphine.
    Mello NK; Mendelson JH
    Drug Alcohol Depend; 1985 Feb; 14(3-4):283-303. PubMed ID: 3888577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP; Lukas SE
    J Pharmacol Exp Ther; 1990 Sep; 254(3):926-39. PubMed ID: 2395121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study.
    Mendelson JH; Mello NK; Teoh SK; Kuehnle J; Sintavanarong P; Dooley-Coufos K
    NIDA Res Monogr; 1990; 105():196-202. PubMed ID: 1875999
    [No Abstract]   [Full Text] [Related]  

  • 9. Unreinforced self-injections: effects on rituals and outcome in heroin addicts.
    O'Brien CP; Greenstein R; Ternes J; McLellan AT; Grabowski J
    NIDA Res Monogr; 1979; 27():275-81. PubMed ID: 95035
    [No Abstract]   [Full Text] [Related]  

  • 10. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
    Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
    Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin detoxification with a single high dose of buprenorphine.
    Kutz I; Reznik V
    Isr J Psychiatry Relat Sci; 2002; 39(2):113-9. PubMed ID: 12227226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
    Digiusto E; Lintzeris N; Breen C; Kimber J; Mattick RP; Bell J; Ali R; Saunders JB;
    Addict Behav; 2005 Mar; 30(3):443-56. PubMed ID: 15718062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detoxification of heroin dependence by buprenorphine.
    Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
    White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
    Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys.
    Mello NK; Negus SS
    J Pharmacol Exp Ther; 1998 May; 285(2):444-56. PubMed ID: 9580582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New supportive therapy with naltrexone. Care of heroin addiction in the United States].
    Rimailho A
    Rev Prat; 1987 May; 37(29):1751-5. PubMed ID: 3589443
    [No Abstract]   [Full Text] [Related]  

  • 20. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.